SEATTLE — A Washington judge has ordered Albertsons Companies to pay $900 million for its pharmacies' role in fuelling the state's opioid crisis, in what the state says is the largest verdict in Washington history. The Albertsons opioid verdict, delivered on Thursday, November 5, 2026, by King County Superior Court Judge Janet Helson, followed a nine-week bench trial. The award is $800 million for abatement, paid into a court-supervised trust, plus $100 million in civil penalties.

The ruling is a landmark in the long legal reckoning over the American opioid epidemic. Washington refused to join Albertsons' $774 million national settlement announced in April 2026, choosing instead to take its own case to trial.

Key Points

• Judge Janet Helson ordered Albertsons to pay $900 million — $800 million in abatement plus $100 million in civil penalties — after a nine-week trial.
• Between 2006 and 2022, Albertsons pharmacies in Washington dispensed over 641 million opioid pills and filled 6.5 million flagged prescriptions.
• The court found that 96% of flagged prescriptions lacked documented proof that pharmacists investigated and resolved the concerns.
• A permanent injunction requires Albertsons to strengthen screening and monitoring at its more than 200 Washington pharmacies.
• Albertsons says it is disappointed, disagrees with the ruling and is reviewing its options, including an appeal.

What Happened

Judge Helson issued her ruling on Thursday, November 5, 2026, ending a bench trial that ran from July 13 to September 14, 2026. The court heard from 45 witnesses and reviewed more than 600 exhibits, to decide whether Albertsons' pharmacies had failed in their duty to check suspicious opioid prescriptions. The judge found that they had.

Her ruling concluded that Albertsons violated state and federal law by failing to maintain safeguards that could identify and resolve "red flags" — warning signs that a prescription might be illegitimate, such as unusually large quantities or doctors prescribing far outside normal practice. The scale was enormous: of the more than 6.5 million prescriptions that triggered red flags, 96% had no sufficient documentation that a pharmacist had investigated the concern before handing over the drugs.

Attorney General Nick Brown, whose office brought the case, said the award is believed to be the largest verdict in state history. The $800 million abatement portion will go into a court-supervised trust.

Background: How Washington Built Its Case

Washington state sued Albertsons and several other pharmacy chains in 2022, arguing that the companies had substantially contributed to the opioid epidemic by flooding communities with prescription painkillers while ignoring obvious signs of misuse and diversion. Most similar cases across the country ended in settlements, but Washington opted out of Albertsons' national deal and pressed ahead with its own trial.

The trial focused on the pharmacies Albertsons operates under its own name and under the Safeway and Haggen banners in Washington — more than 200 stores. The state argued pharmacists were the last line of defence between a suspicious prescription and a patient. The ruling put it bluntly: "Albertsons possessed, but routinely disregarded or ignored, information and tools that could have helped prevent diversion, choosing sales and profits over patient safety."

Albertsons Opioid Verdict: What the Court Found

Among the most striking findings was the court's account of five so-called "pill mill" doctors. The ruling noted Albertsons filled 5.5 million prescriptions from five Washington doctors who later had their licences suspended or revoked. Those prescriptions alone accounted for a large share of the pills that flowed through the company's pharmacies.

The judge also found that Albertsons had a duty not only to maintain systems that could identify suspicious prescriptions, but to report those red flags to the authorities. That duty, the court said, was not met — a pattern sustained over a decade and a half. Alongside the money, the court imposed a permanent injunction requiring Albertsons to strengthen its prescription screening and monitoring of controlled substances at its Washington pharmacies.

Reactions and Quotes

Albertsons said in a statement that it is "disappointed" by the ruling, disagrees with the court's conclusions and is evaluating its options, including an appeal. "We are proud of our pharmacists and their dedication to the patients and communities they serve, and we will continue to support our customers and communities across Washington through responsible pharmacy operations," Albertsons said in its statement.

At trial, the company's defence was that its pharmacies could not be blamed for prescriptions written by doctors. Its pharmacies, the company argued, "are a mirror of what the doctors are doing." The judge rejected that argument, finding that pharmacists have an independent duty to question suspicious prescriptions rather than simply fill them.

For the state, the verdict vindicates a strategy that carried real risk. Attorney General Brown's office has presented the result as a historic win for Washington families harmed by the opioid crisis.

Why It Matters

The $900 million award matters first because of where the money is going. The $800 million abatement portion will be paid into a court-supervised trust, earmarked for treatment, prevention and recovery services rather than disappearing into the state's general budget.

The verdict also matters for accountability in the pharmacy industry. Drug makers and distributors have paid billions in settlements over their roles in the epidemic, but this ruling is among the strongest judicial findings yet that a pharmacy chain failed in its gatekeeping role. For Albertsons, the blow lands at a difficult moment: the national settlement contributed to a net loss of nearly $500 million in the fourth quarter of fiscal 2025.

What Happens Next

Albertsons is expected to decide quickly whether to appeal. The company has said it is reviewing its options, and an appeal would move the case to a higher Washington court. An appeal would not necessarily delay the injunction, which requires the company to strengthen its pharmacy screening and monitoring now. The court will also set the fees and costs Albertsons must pay, and the court-supervised trust will need to be established so the abatement money can begin flowing to opioid-related programmes.

Frequently Asked Questions

How much must Albertsons pay in the Washington opioid case?

Judge Janet Helson ordered Albertsons to pay $900 million: $800 million for abatement into a court-supervised trust, plus $100 million in civil penalties, with fees and costs to follow.

Why did Washington sue Albertsons over opioids?

The state argued that Albertsons pharmacies substantially contributed to the opioid epidemic by filling millions of flagged prescriptions without properly investigating them. Between 2006 and 2022, the company's Washington pharmacies dispensed more than 641 million opioid pills.

Is the $900 million the largest verdict in Washington history?

Attorney General Nick Brown said it is believed to be the largest verdict in state history. The award is larger than Albertsons' $774 million national opioid settlement framework announced in April 2026.

Will Albertsons appeal the verdict?

Albertsons has not yet said. The company said it is disappointed, disagrees with the ruling and is reviewing its options, including an appeal to a higher Washington court.

What does the permanent injunction require Albertsons to do?

The injunction requires Albertsons to strengthen prescription screening and monitoring of controlled substances at its more than 200 Washington pharmacies.

Related coverage: Marathon Health data breach and XSOLIS AI breach exposes 14 million patients.